BIRAC Opens First Call Under Rs 1 Lakh Crore RDI Fund
The Biotechnology Industry Research Assistance Council (BIRAC) has officially announced its inaugural call for proposals under the Research, Development and Innovation (RDI) Fund, marking a transformative milestone for India’s biotechnology ecosystem. This groundbreaking initiative, valued at Rs 1 lakh crore, aims to accelerate innovation across biotechnology and allied sectors through strategic funding mechanisms designed specifically for startup growth and technological advancement.
Strategic Framework for Biotech Startup Funding
Understanding the RDI Fund Structure
Following the Technology Development Board’s (TDB) recent announcement, BIRAC emerges as the second organization nominated by the government as a second-level fund manager. While TDB focuses broadly on sunrise and strategic sectors, BIRAC concentrates exclusively on biotechnology and related domains, ensuring specialized support for this critical industry vertical.
The fund’s strategic design targets startups and companies with Technology Readiness Level 4 and above, specifically supporting ventures that have progressed beyond theoretical concepts into practical development stages. This approach ensures funding reaches entities demonstrating tangible innovation potential and market viability.
Eligibility Requirements and Investment Criteria
To qualify for RDI funding, applicants must meet specific prerequisites. Companies must maintain headquarters in India with majority domestic ownership, ensuring the fund primarily benefits Indian innovation ecosystems. This requirement strengthens local entrepreneurship while promoting indigenous technological capabilities across biotechnology sectors.
Comprehensive Investment Routes and Financial Models
Three-Tier Funding Mechanism
BIRAC has structured its investment approach through three distinct routes, each tailored to different funding requirements:
Tier 1: Optionally Convertible Preference Shares (OCPS) – For investments reaching Rs 25 crore, BIRAC utilizes OCPS instruments, providing flexible capital structures that balance investor protection with startup growth needs.
Tier 2: Hybrid Equity-OCPS Model – Projects requiring between Rs 25 crore and Rs 50 crore receive partial equity share capital combined with OCPS, creating balanced capital structures supporting larger development initiatives.
Tier 3: Unsecured Loan Framework – Investments exceeding Rs 50 crore are structured as unsecured loans carrying 2-3 percent annual interest rates, offering competitive financing terms for substantial biotechnology ventures.
The RDI Fund covers up to 50 percent of total assessed project costs, with project proponents responsible for matching contributions through self-financing or commercial sources. This co-investment model ensures startups maintain financial discipline while accessing substantial development capital.
Streamlined Evaluation and Disbursement Processes
Rapid Assessment Timeline
Jitendra Kumar, BIRAC’s Managing Director, emphasized the organization’s commitment to efficiency, confirming application evaluations will complete within eight weeks of submission. Following approval, fund disbursement occurs within 12 weeks of evaluation completion, significantly reducing traditional funding timeline challenges.
An investment committee comprising 6-8 members from industry and investment communities conducts thorough proposal evaluations, ensuring expert assessment of technical feasibility, commercial viability, and innovation potential. This specialized committee brings deep sector knowledge, enhancing funding decision quality.
Initial Allocation and Expected Impact
Launch Phase Expectations
BIRAC anticipates receiving approximately 100 applications during the first week following the announcement, demonstrating strong market interest in biotechnology innovation funding. From these initial submissions, the organization targets final approval for 15 startups, establishing rigorous quality standards while maintaining meaningful program impact.
As a second-level fund manager, BIRAC has received Rs 2,000 crore as initial allocation from the Special Purpose Fund, established under the Anusandhan National Research Foundation. This substantial capital base ensures adequate funding availability for deserving biotechnology ventures.
Government Support and Future Expansion
Continued Budgetary Commitment
In Budget 2026, Finance Minister Nirmala Sitharaman allocated Rs 20,000 crore to the RDI Fund, matching the previous year’s budgetary support. This consistent commitment demonstrates government recognition of research and development’s critical role in national economic competitiveness.
The Department of Science and Technology, serving as the fund’s nodal ministry, plans finalizing additional fund managers by April-May 2026. These new managers will require approximately 6-8 months for investment decision processes, gradually expanding the RDI Fund’s reach across multiple innovation sectors.
